Develop adverse event prediction and plaque phenotype classification models using plaque morphology and composition assessment of CTA which has been validated by histology, applied to representative cohort of patients. Generalizability of models is enhanced by using validated rather than only raw image inputs. Demographic, clinical, and outcome data is collected for enrolled patients as well as information on events and interventions.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subjects must have two (or more) neck CTAs at least 6 months apart of sufficient quality as documented in the vascuCAP Reading Manual.
Atherosclerotic plaque must be visualized within the carotid artery.
You may not be if
Subjects without visible plaque within the carotid artery
Subject with insufficient CTA image quality (defined strictly as documented in the vascuCAP Reading Manual)